DynaCirc CR is a brand name of isradipine, approved by the FDA in the following formulation(s):
DYNACIRC CR (isradipine - tablet, extended release; oral)
Manufacturer: GLAXOSMITHKLINE LLC
Approval date: June 1, 1994
Strength(s): 10MG [RLD], 5MG
Has a generic version of DynaCirc CR been approved?
No. There is currently no therapeutically equivalent version of DynaCirc CR available.
Note: Fraudulent online pharmacies may attempt to sell an illegal generic version of DynaCirc CR. These medications may be counterfeit and potentially unsafe. If you purchase medications online, be sure you are buying from a reputable and valid online pharmacy. Ask your health care provider for advice if you are unsure about the online purchase of any medication.
See also: About generic drugs.
Related Patents
There are no current U.S. patents associated with DynaCirc CR.
See also...
- DynaCirc CR Extended-Release Tablets Consumer Information (Wolters Kluwer)
- Dynacirc CR Consumer Information (Cerner Multum)
- Dynacirc CR Advanced Consumer Information (Micromedex)
- Isradipine Consumer Information (Wolters Kluwer)
- Isradipine Extended-Release Tablets Consumer Information (Wolters Kluwer)
- Isradipine Consumer Information (Cerner Multum)
- Isradipine Advanced Consumer Information (Micromedex)
- Isradipine AHFS DI Monographs (ASHP)
No comments:
Post a Comment